Pay Attention to ADHD

Published Online: Wednesday, April 17, 2013
Follow Pharmacy_Times:
In this podcast, Susanna Visser, MS, an epidemiologist from the Centers for Disease Control and Prevention’s National Center on Birth Defects and Developmental Disabilities, discusses the symptoms of and treatment for ADHD. To listen to the podcast online, click here. To download, click here.
Related Articles
The FDA has added a new warning to the drug label of the methylphenidate transdermal system indicated for ADHD to describe permanent loss of skin color, also known as chemical leukoderma.
An increasing number of adults receiving prescription stimulant medications challenge the notion that ADHD is a children’s condition and create new obstacles for pharmacists.
Four separate drug manufacturers have launched generic versions of Shire’s Intuniv ADHD treatment for children aged 6 to 17 years.
The FDA had accepted for review Tris Pharma’s New Drug Application for its extended-release liquid amphetamine to treat ADHD in children.
Latest Issues
$auto_registration$